Maple Capital Management’s T. Rowe Price Blue Chip Growth ETF TCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$500K Sell
9,989
-3,938
-28% -$197K 0.03% 77
2026
Q1
$615K Sell
13,927
-4,596
-25% -$217K 0.04% 68
2025
Q4
$924K Sell
18,523
-16,388
-47% -$811K 0.06% 58
2025
Q3
$1.71M Sell
34,911
-5,984
-15% -$282K 0.11% 42
2025
Q2
$1.85M Buy
40,895
+1,332
+3% +$54.2K 0.13% 43
2025
Q1
$1.51M Buy
39,563
+3,631
+10% +$151K 0.12% 50
2024
Q4
$1.51M Buy
35,932
+10,616
+42% +$441K 0.11% 49
2024
Q3
$1M Buy
25,316
+6,946
+38% +$266K 0.08% 52
2024
Q2
$711K Buy
18,370
+11,008
+150% +$397K 0.06% 58
2024
Q1
$260K Buy
+7,362
New +$246K 0.02% 95

Other funds holding TCHP

Maple Capital Management's TCHP Position: Q2 2026 in Review

Maple Capital Management reduced its T. Rowe Price Blue Chip Growth ETF (TCHP) stake by 28% in Q2 2026, selling an estimated $197K and leaving 9,989 shares worth $500K. The position accounts for 0.03% of the portfolio, ranked #77.

Maple Capital Management first reported a position in TCHP in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.85M in Q2 2025. 184 funds tracked by Wall St. Rank hold TCHP as of Q2 2026.

  • Maple Capital Management held 9,989 shares of T. Rowe Price Blue Chip Growth ETF worth $500K as of Q2 2026.
  • Maple Capital Management sold 3,938 T. Rowe Price Blue Chip Growth ETF shares in Q2 2026, an estimated $197K.
  • T. Rowe Price Blue Chip Growth ETF made up 0.03% of Maple Capital Management's portfolio in Q2 2026, its #77 holding.
  • Maple Capital Management first reported a position in T. Rowe Price Blue Chip Growth ETF in Q1 2024 and has held it in 10 quarters since.
  • Maple Capital Management's T. Rowe Price Blue Chip Growth ETF position peaked at $1.85M in Q2 2025.
  • 184 funds tracked by Wall St. Rank held T. Rowe Price Blue Chip Growth ETF as of Q2 2026.

Based on Maple Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.